New independent private equity firm Ten Coves Capital has assumed the management of two Napier Park Financial Partners growth equity funds, with an aggregate of USD325 million in committed capital, and will continue to support existing growth equity portfolio companies and investors.The firm will be led by Managing Partners Steve Piaker, Dan Kittredge and Ned May, who will be joined by Steve Lula and Kyle Kruse. Manu Rana will participate as a Founding Partner and Senior Advisor; he will remain a Partner at Napier Park continuing to lead their real assets investment business.   “The launching of the Ten Coves

Fintech company Outfund has closed a GBP37million late seed round of capital, including debt and equity. The funding round was led by Fuel Ventures and sees TMT Investments and Force Over Mass also invest in Outfund as it provides a faster, fairer and more affordable way for SMEs to raise growth capital. The pandemic is driving more people to shop online with an expected 19% increase in e-commerce sales  and with the “golden retail quarter” upon us, many businesses will need to grow and sell more on the web in order to grow revenues and profitability. This means investing more capital

Arma Partners has acted as exclusive financial advisor to Exclaimer, a portfolio company of Livingbridge, on its sale of a majority stake to Insight Partners with participation from Farview Equity Partners. Livingbridge will reinvest alongside Insight Partners and Farview Equity Partners as a minority shareholder to retain equity exposure to the growth of the company under its new ownership structure. Founded in 2001, Exclaimer offers centralised email signature management software to more than 40,000 customers. These solutions enable companies of all sizes to manage their employees’ signatures efficiently and deliver consistent branding, promotions, disclaimers and compliance statements, while substantially saving time,

Gaia Capital Partners has masde its first investment in the UK in a USD40 million growth round for gohenry alongside US funds Edison Partners, Citi Ventures and Muse Capital. This is its fourth investment in one year after Welcome to the Jungle in late 2019, Aircall last spring and Yubo in November 2020. For all of these growth rounds, Gaia Capital Partners has co-invested alongside leading international investors. Launched in the UK in 2012 on a mission to innovate both financial education and digital banking, gohenry is a financial education app and prepaid debit card, in partnership with Visa in the

Finland-based startup Rundit, a platform for portfolio management and monitoring, has raised EUR1 million in seed funding to further its mission of making investor reporting easy and transparent so that VCs and LPs can make better data-driven decisions.The round was led by two new angel investors, including Pierre Weimerskirch, board member of several PE and VC funds and the LPEA Luxembourg Private Equity Association. The capital will be used for scaling across Europe and the US, while improving Rundit’s product offering for GPs. “We are excited to have the backing of our strategic angel investors who can help us accelerate

Admincontrol and Dealsuite have entered into a global strategic partnership, combining Dealsuite’s leading M&A platform with Admincontrol’s world class virtual data room solution.  Admincontrol, the Nordic market leading provider of Virtual Data Rooms and part of the Visma Group, opened their Dutch office in March 2020. Now the Norwegian company has entered a global strategic partnership with Dealsuite to further strengthen their presence in Europe.    Dealsuite is Europe’s leading M&A community for dealmakers: M&A advisors, PE firms and corporates. These M&A professionals use the powerful business tool Dealsuite.com to find new (proprietary) deal opportunities. Dealsuite specializes in the middle market

Arlington Capital Partners (Arlington Capital), a Washington, DC-based private equity firm, has made a majority investment in Everest Clinical Research Corporation (Everest), alongside the company’s founding shareholders and senior management who will continue to lead the firm.”Founded in 2004 and headquartered in Toronto, Canada, Everest is a leading contract research organisation (CRO) providing a comprehensive suite of mission-critical clinical research services to the worldwide pharmaceutical, biotechnology, and medical device industries across Phase I-IV trials. Throughout the Company’s history, Everest has focused on providing exceptional quality, customer service, and on-time delivery to its partners to advance life-changing research. Everest employs over